Related Experiment Videos

A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling

Shengliang Zhang1, Masaya Fukushi, Shinichi Hashimoto

  • 1Department of Molecular Cellular Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo 113, Japan.

Insights

Nef-associated factor 1 alpha (Naf1 alpha) binds and is phosphorylated by ERK2 signaling. Overexpressing Naf1 alpha suppresses ERK2 nuclear translocation, attenuating downstream gene activation.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Signal transduction mechanisms

Background:

  • Extracellular signal-regulated kinases (ERK1/2) are crucial regulators of cell growth, differentiation, and death.
  • Understanding the precise mechanisms of ERK1/2 signaling in human cells is essential for comprehending cellular processes.

Purpose of the Study:

  • To identify novel proteins interacting with ERK2.
  • To elucidate the role of Naf1 alpha in the ERK2 signaling pathway.

Main Methods:

  • Yeast two-hybrid system for protein interaction discovery.
  • Pull-down assays and immunoprecipitation for binding validation.
  • Analysis of ERK2 nuclear translocation and downstream transcriptional activity in Naf1 alpha-expressing cells.

Main Results:

  • Naf1 alpha was identified as an ERK2-binding protein.
  • Naf1 alpha is phosphorylated by the EGF/MEK/ERK2 pathway.
  • Overexpression of Naf1 alpha inhibited ERK2 nuclear translocation and downstream Elk1-driven transcription.

Conclusions:

  • Naf1 alpha acts as a negative regulator or attenuator of activated ERK2 signaling.
  • Naf1 alpha influences ERK2's ability to translocate to the nucleus and activate target genes.

Related Concept Videos